Serum Institute of India (SII) Executive Director Adar Poonawalla said on Saturday that the COVID-19 The vaccination campaign may start in January 2021, as his company hoped to obtain the emergency use authorization by the end of this month. India today reported. Poonawalla said he hoped everyone in India would …
Read More »Serum Institute Likely To Supply Covid-19 Vaccine At ₹ 250 Per Dose: Report
BENGALURU: The Serum Institute of India, the world’s largest producer of vaccines by volume, is close to signing a supply contract with the country’s central government and is likely to set prices at 250 rupees ($ 3.39) per dose of the vaccine, Business Standard reported Tuesday: citing people familiar with …
Read More »Serum ready to deal with the Center soon; supply the vaccine at 250 rupees a dose: Report | India News
BENGALURU: Serum Institute of India, the largest in the world vaccine producer by volume, is close to signing a supply contract with the country. central government and it is likely to set prices at 250 rupees ($ 3.39) per dose of the vaccine, a business newspaper reported Tuesday, citing people …
Read More »Adar Poonawalla from IBS Confirms Request for Emergency Use of COVISHIELD Vaccine; thanks PM
After US pharmaceutical giant Pfizer, Serum Institute of India (SII) applied on Sunday to the Comptroller General of Medicines of India (DCGI) for an emergency use authorization for the COVID-19 Covidshield vaccine from Oxford in the country. On Twitter, SII CEO Adar Poonawalla reported that the company has applied for …
Read More »Serum Institute’s Adar Poonawalla Named Among 6 ‘Asians of the Year’: Report
Adar Poonawalla is the CEO of the world’s largest vaccine manufacturer, Serum Institute of India. Singapore: Adar Poonawalla, CEO of the Serum Institute of India, the world’s largest vaccine manufacturer, is among the six people named “Asians of the Year” by Singapore’s leading daily, The Straits Times, for his work …
Read More »Adar Poonawalla of the Serum Institute of India among the 6 named ‘Asians of the year’ by the Singapore newspaper
Adar Poonawalla, CEO of the world’s largest vaccine maker, Serum Institute of India, is among six people named “Asians of the Year” by Singapore’s leading daily, The Straits Times, for his work in fighting the pandemic. of Covid-19. Pune-based Serum Institute of India (SII) has collaborated with Oxford University and …
Read More »Request for emergency use of the Covid vaccine in 2 weeks: Serum Institute
Adar Poonawalla said that he discussed the implementation plan with PM Modi. The Serum Institute will request in two weeks the emergency use of the coronavirus vaccine being developed by the University of Oxford and the pharmaceutical giant AstraZeneca, the head of the vaccine manufacturer, Adar Poonawalla, said on Saturday …
Read More »Adar Poonawalla announces 100 million doses of Oxford vaccine for January
Earlier this year, front-line workers such as doctors and nurses were said to be the first to get vaccinated, NDTV reported. When will the vaccine be available to the general public? Speaking at the Hindustan Times Leadership Summit 2020, Poonawalla said: “I never dreamed that at the Serum Institute of …
Read More »India is the first priority for the administration of the Covid-19 vaccine: Serum Institute
India will take the top priority for the delivery of the AstraZeneca / Oxford vaccine after its British developers claimed success after massive testing, the world’s largest vaccine maker by volume said Monday. Serum Institute of India CEO Adar Poonawalla said the manufacturer has already produced 40 million doses of …
Read More »Limited use of Oxford vaccine should be available in India in late December or early January: Serum CEO
New Delhi: Hours after the promising results of the Oxford-AstraZeneca Covid vaccine were released, the executive director of the Serum Institute Of India said Monday that the company can supply up to 400 million doses of the vaccine by July 2021. Adar Poonawalla told a trade news channel that the …
Read More »